poisar

Stocks · News reference

Leerink Partners Maintains Buy Rating and Raises Price Target for Veradermics

Fiscal.ai

Leerink Partners analyst Marc Goodman has maintained a "Buy" rating on Veradermics, Incorporated and increased the price target from $150 to $185.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Veradermics, Inc (MANE)

    Filed: 2026-11-10 AccNo: 0001827635-26-000041 Size: 641 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits